We're proud to announce that Principal Cardiovascular Scientist Masliza Mahmod, was awarded Fellow of the European Society of Cardiology in Munich, pictured with ESC Vice President Prof Marco Roffi. Congratulations, Masliza!

#Perspectum #ESCCongress

Could conduction-system pacing become a viable resynchronization strategy? In His-Alternative II, the strategy was noninferior to biventricular pacing for reverse remodeling in patients with HFrEF. www.tctmd.com/news/his-alt... #ESCCongress

The findings in the phase II TRANQUILITY trial reinforce pacibekitug’s anti-inflammatory effect, but leaves its potential impact on cardiovascular outcomes unresolved. Read more: www.tctmd.com/news/tranqui... #ESCCongress

Med News: Explore the top cardiology highlights from #ESCCongress 2026.

In this Q&A, conference chair Tomasz Guzik, MD, PhD, discusses blood pressure control for dementia prevention, a new global definition of myocardial infarction, and more updates.

RISE @ ESC Congress 2026 brought together global women in cardiology and allies to learn, connect, and grow as leaders.

Thank you to our sponsors for investing in greater opportunities for women and a more inclusive future for cardiology. 💛

#LetsRISE26 #ESCCongress #CardioSky

✨ #ESCCongress 2026: Weniger Demenz durch intensive #Blutdruckkontrolle?
🔬 Studie: CRHCP
🎙️Präsentiert von: Prof. Yingxian Sun
🔍 Prof. Marcel Halbach berichtet & ordnet die Ergebnisse ein.
➡️ herzmedizin.de/fuer-aerzte-...
#DGK #Kardiologie #CardioSky

POPular ACT TAVI results, presented earlier this month at #ESCCongress, reveal that routine protamine reduces the composite outcome of all-cause death or bleeding. The findings still leave room for debate over whether this will change practice. Read more:
www.tctmd.com/news/routine...

✨ #ESCCongress 2026: Weniger Demenz durch intensive #Blutdruckkontrolle?
🔬 Studie: CRHCP
🎙️Präsentiert von: Prof. Yingxian Sun
🔍 Prof. Marcel Halbach berichtet & ordnet die Ergebnisse ein.
➡️ herzmedizin.de/fuer-...
#DGK #Kardiologie #CardioSky

We’re excited to share photos from a memorable day in Munich at RISE @ ESC Congress 2026.

From practical learning to new connections, thank you to everyone who made RISE such a meaningful part of #ESCCongress.

📸 Explore the photo gallery: flic.kr/s/aHBqjD4swE

#LetsRISE26 #CardioSky

❓How will #AI and #wearables shape the future of metabolic and cardiovascular risk assessment and care?
Anca Pantea Stoian points out highlights from the @escardio.bsky.social and EASD Joint Session at the #ESCCongress 2026.
Watch here👉 easd-elearning.eu/news/480/Fro...

#ESCCongress 2026: Combining direct oral anticoagulants with powerful P2Y12 inhibitors in atrial fibrillation and acute coronary syndrome patients shows higher bleeding risk without lower ischemic events, compared to using clopidogrel and aspirin.

As presented at the 2026 #ESCCongress: A secondary analysis of the CARDIOTTRansform trial revealed that eplontersen benefited patients with transthyretin amyloid cardiomyopathy who were not on stabilizers, but not those who were.

"Every way, shape, or form you look at this there was benefit." -- Ahmad Masri, MD, of @ohsunews.bsky.social Medical Group, discussing results from a trial of aficamten (Myqorzo) in symptomatic nonobstructive hypertrophic cardiomyopathy. #ESCCongress
www.medpagetoday.com/meetingcover...

From #ESCCongress 2026: The addition of low-voltage zone ablation to pulmonary vein isolation in patients with persistent atrial fibrillation significantly improves rhythm outcomes, shows the IDEAL-AF trial.

👉️ buff.ly/7794B8P

#MedNews #CardioSky

From #ESCCongress 2026: Immediate initiation of evolocumab before PCI for acute myocardial infarction leads to rapid reductions in low-density lipoprotein cholesterol, but does not improve 1-year clinical outcomes.

👉️ buff.ly/JQacbgt

#MedNews #CardioSky

Routine referral of patients with #ProstateCancer to a #Cardiovascular specialist improved cholesterol control and overall risk factor management, but did not reduce major cardiovascular events vs usual care. #ESCCongress ja.ma/46GGlwN

From #ESCCongress 2026: Among individuals with left-sided infective endocarditis participating in the POET II trial, a response-tailored antibiotic strategy reduced treatment duration by 2 weeks.

👉️ buff.ly/hnd8aUv

#IDMed #CardioSky

From #ESCCongress 2026: Beta blockers could be discontinued in stable patients with a history of MI if they have a LVEF of at least 40%, no heart failure, and no other indication for such therapy, suggests a pooled analysis.

👉️ buff.ly/MVe4q5G

#MedNews #CardioSky

From #ESCCongress 2026: Patients with intermediate-high-risk acute pulmonary embolism may benefit from receiving catheter-directed thrombolysis with alteplase in addition to anticoagulation therapy.

👉️ buff.ly/EoCnO90

#MedNews #CardioSky

Professor @Bharatishivalka, spoke about her experience at RISE @ ESC Congress 2026 and why it’s essential for women in all career stages.

Sign up to The Pulse today to learn about future networking and mentoring opportunities - womenasonepulse.org

#LetsRISE26 #ESCCongress #CardioSky